Latest
Hot
Options especially selling puts are never for the faint hearted. Staying optimistic on their continued growth end of year.
$Tesla (TSLA.US)$ $Apple (AAPL.US)$
$Tesla (TSLA.US)$ $Apple (AAPL.US)$



11
I will be avoiding stocks that declare a mixed shelf offering. A mixed shelf offering is an offering that stays open until the price is reached or 3 years. Once announced they wont announce it again in the hope that investors will forget about it. Once a mixed shelf is filed, anytime the stock goes up they can and will add shares. There are no long term gains because the stock just stays sideways. And unless you watch the stock all day and sell as soon as a spike happens you wont have s...
22
3
1
$Novavax (NVAX.US)$ $CureVac (CVAC.US)$
In April, I evaluated Novavax (NVAX) as a wise investment choice. At that time, Novavax's stock price was around $4, and now, within just a few months, it has soared to $20, a more than 500% increase. If you had invested $10,000 back then, it would have grown to $50,000 now. However, my post did not receive the recognition it deserved, and many people dismissed the idea, claim...
In April, I evaluated Novavax (NVAX) as a wise investment choice. At that time, Novavax's stock price was around $4, and now, within just a few months, it has soared to $20, a more than 500% increase. If you had invested $10,000 back then, it would have grown to $50,000 now. However, my post did not receive the recognition it deserved, and many people dismissed the idea, claim...


11
2
I'm following the old "invest in what you know" tactic and sticking with drug development. I thought I would split my portfolio between big pharma as"value stocks." Smaller bio-techs with only a handful of drug candidates I see as a type of "growth stock" that is perhaps overly speculative.
I wanted to ask for the community's recommendations if this was a good way to structure the portfol...
I wanted to ask for the community's recommendations if this was a good way to structure the portfol...
loading...
2
2
After the last release of Tencent's financial report, I quickly judged Tencent's investment value and made the judgment that Tencent has a high investment value. At present, Tencent has announced its first quarter results as of March 31, 2024. The financial report shows:
- Revenue was 159.501 billion yuan (RMB, the same below), a year-on-year increase of 6%;
- Net profit was 41.889 billion yuan, a year-on-year increase of 62%;
- Adjusted net profit was 50.265 bi...
- Revenue was 159.501 billion yuan (RMB, the same below), a year-on-year increase of 6%;
- Net profit was 41.889 billion yuan, a year-on-year increase of 62%;
- Adjusted net profit was 50.265 bi...
11
There is an old saying 'sell in may' and go away, but after I crunched the numbers, I found this statement to be WRONG and OUTDATED. If you sold in May, you would be missing out on potentially some of the best months of the year for US and Aussie shares. Instead I think investors should be focusing on their own strategy investment targets.
In the US November has historically been the best month of the year for th...
In the US November has historically been the best month of the year for th...


10
4
2
$LUMIRADX LTD C/WTS 28/09/2026 (TO PUR COM) (LMDWF.US)$
I’m coming in late into this which sucks but whatever happened here.? is thete still life and who’s still holding.?
I’m coming in late into this which sucks but whatever happened here.? is thete still life and who’s still holding.?
Columns If stock picking is not for you, consider investing in an actively managed ETF, like this one AGX1
If you don't know what to invest in on the ASX in 2024 then this video is for you.
Maybe you don't want to pick stocks, and want to sleep at night and you want something that is managed for you. Welll you could be in luck. I sat down with Antipodes, a renowned global equities investment manager.
Vihari Ross is a Portfolio Manager with Antipodes and gave her stock pick for 2024, and that is to inve...
Maybe you don't want to pick stocks, and want to sleep at night and you want something that is managed for you. Welll you could be in luck. I sat down with Antipodes, a renowned global equities investment manager.
Vihari Ross is a Portfolio Manager with Antipodes and gave her stock pick for 2024, and that is to inve...

4
Was great to be on ausbiz yesterday with Andrew Geoghegan, chatting out the week ahead.
Catch it here.
We spoke about everything from the risk of a US market correction, as in the S&P500 could fall 5-7% from its current levels. BUT market bulls could buy into any weakness should the market fall 5-7%, because end of quarter rebalancing will likely take effect, plus the notion remains that this year is going ...
Catch it here.
We spoke about everything from the risk of a US market correction, as in the S&P500 could fall 5-7% from its current levels. BUT market bulls could buy into any weakness should the market fall 5-7%, because end of quarter rebalancing will likely take effect, plus the notion remains that this year is going ...

4
2
1